News

Press Center
The Russian tokenization platform Atomyze, where Vladimir Potanin's Interros is one of the investors, received the operator status of an information system for managing digital financial assets (DFA) from the Central Bank. In accordance with the recently adopted law on DFA in Russia, the regulator granted the rights to issue and circulate DFA in exchange for Russian rubles, as well as to store DFA, maintain a register of holders and to support electronic accounts and channels for servicing DFA holders. More
Topics Atomyze / Vladimir Potanin / Interros / DFA
Building on the success of Rosa Khutor resort, the $1 bln project will bring quality hotels and rehabilitation facilities, new skiing tracks for over a million of visitors per year while creating thousands of new jobs More
Topics Interros / VEB.RF / Vasta Discovery / Sochi
18.06.2021
Interros has not applied for the buyback of its Norilsk Nickel shares. As a result of the buyback, Interros share in Norilsk Nickel will increase, which is in line with our long-term strategy.
More
Topics Interros / Norilsk Nickel / buyback 
22.07.2020
A Russian original medication called Polyoxidonium® by Petrovax, a pharmaceutical company affiliated to the Interros Group, has passed the first phase of an international clinical trial for its effectiveness and safety for COVID-19 treatment.
More
Topics Petrovax Pharm 
17.04.2020
Polyoxidonium (azoximer bromide) - the Russian original drug produced by Petrovax- was approved by the Ministry of Health of the Russian Federation for conducting an international clinical trial for the treatment of COVID-19.
More
Topics Petrovax Pharm